Acceptability Of Testing DNA Markers In Vaginal Fluid For The Detection Of Endometrial Cancer

Overview

About this study

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* Self-identified Black individuals ≥ 45 years with an intact uterus
* Assigned female sex at birth
* Willing to participate in a 30-minute virtual interview

Exclusion Criteria:

* Previous or current diagnosis of endometrial cancer

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/01/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shariska Harrington, M.D.

Open for enrollment

Contact information:

Kelly Gunderson

5074221892

gunderson.kelly@mayo.edu

More information

Publications

Publications are currently not available